Welcome!

Microsoft Cloud Authors: Yeshim Deniz, Janakiram MSV, Andreas Grabner, Stackify Blog, Liz McMillan

News Feed Item

MDxHealth Provides Third Quarter 2012 Business Update

IRVINE, CA and LIEGE, BELGIUM -- (Marketwire) -- 11/15/12 -- MDxHealth SA (EURONEXT BRUSSELS: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today published a business update for the third quarter ending September 30, 2012.

Highlights
In Q3 2012, MDxHealth made significant progress across all facets of its business. On July 4, 2012, the company raised EUR 10 million in new equity funding via a private placement. As of September 30, 2012, the company had EUR 13.9 million of cash on hand. Commercial product and service revenues in Q3 increased 142% compared to the same period last year, with total revenues of EUR 2.9 million in the first nine months of 2012, an increase of 90% versus the same period in 2011.

The commercial roll-out of ConfirmMDx™ for Prostate Cancer, launched at the end of May of this year, is advancing according to expectations. In July, MDxHealth signed a collaboration agreement with Merck KGaA for the development and worldwide commercialization of MDxHealth's MGMT diagnostic test, PredictMDx™ for Glioblastoma.

In August, the company received CAP (College of American Pathologists) accreditation, as well as licenses from Florida and Pennsylvania, for its CLIA reference laboratory in Irvine, CA.

"We are very pleased with the acceptance of the ConfirmMDx for Prostate Cancer test among the US urology community as evidenced by our sales growth. The rising market awareness and adoption of the ConfirmMDx test reflect increasing momentum of our sales and marketing efforts," said Dr. Jan Groen CEO of MDxHealth. "Based on the favorable market reception, it is clear that our epigenetic test provides urologists with valuable information to help address false-negative biopsy concerns with their patients. This early success gives me confidence that ConfirmMDx will also deliver value for the company and its shareholders."

Key non-audited financials as of September 30, 2012

Amounts as at and for the three months ended

----------------------------------------------------------------------
Euro thousands                   Sept 30, 2012        Sept 30, 2011
----------------------------------------------------------------------
Commercial Revenues                   644                  267
----------------------------------------------------------------------
Total Revenues                        925                  378
----------------------------------------------------------------------
EBITDA (Loss)                       (2,244)              (1,760)
----------------------------------------------------------------------
EBIT Operating Income (Loss)        (2,330)              (1,862)
----------------------------------------------------------------------
Net Profit (Loss)                   (2,321)              (1,879)
----------------------------------------------------------------------
Cash and cash equivalents           13,899               12,916
----------------------------------------------------------------------

Amounts as at and for the nine months ended

----------------------------------------------------------------------
Euro thousands                  Sept. 30, 2012        Sept 30, 2011
----------------------------------------------------------------------
Commercial Revenues                  2,100                1,086
----------------------------------------------------------------------
Total Revenues                       2,939                1,785
----------------------------------------------------------------------
EBITDA Income (Loss)                (6,293)              (5,444)
----------------------------------------------------------------------
EBIT Operating Income (Loss)        (6,590)              (5,713)
----------------------------------------------------------------------
Net Profit (Loss)                   (6,580)              (5,692)
----------------------------------------------------------------------
Cash and cash equivalents           13,899               12,916
----------------------------------------------------------------------

Commercial revenues up 90% for the first 9 months

Revenues
The total revenues for the first nine months of the year amounted to EUR 2.9 million, of which EUR 2.1 million represent commercial revenues, up 90% compared to the same period last year.

Operating Expenses
The company's operating expenses were EUR 9.2 million in the first nine months of 2012, versus EUR 7.3 million in the same period in 2011, as the company continued to invest in the development of its product pipeline and sales and marketing activities in the US.

Cash Position
As of September 30, 2012, MDxHealth had EUR 13.9 million in cash, compared to EUR 12.9 million on September 30, 2011, EUR 1.0 million higher than the same period last year.

Outlook for fourth quarter and FY 2012
In Q4 2012, the company expects to report an increase in commercial product and service revenues compared to previous quarters, primarily due to continuing growth in sales of our ConfirmMDx for Prostate Cancer test in the US and commercial service revenues from our ongoing PharmacoMDx collaborations with Merck Serono, GSK Biologicals and other partners. The health economic study for the ConfirmMDx for Prostate Cancer test, providing healthcare providers with important cost comparison data, is scheduled to be submitted for publication. Total operating costs in Q4 are expected to increase due to higher sales and marketing and other operating activities.

About MDxHealth
MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients. The company's first commercial product, the ConfirmMDx™ for Prostate Cancer test, has been shown to help distinguish patients who have a true-negative biopsy from those who may have occult cancer. MDxHealth helps to address a large and growing unmet medical need for better cancer diagnosis and treatment information. The company has a proprietary platform and a strong epigenetic product pipeline focused on the development of products for brain and lung cancers. The company is based in Irvine, California with a European headquarters in Liege, Belgium. For more information visit MDxHealth website at www.mdxhealth.com.

This press release contains forward-looking statements and estimates with respect to the anticipated future performance of MDxHealth and the market in which it operates. Such statements and estimates are based on assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable but may not prove to be correct. Actual events are difficult to predict, may depend upon factors that are beyond the company's control, and may turn out to be materially different. MDxHealth expressly disclaims any obligation to update any such forward-looking statements in this release to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based unless required by law or regulation.

Q3 2012 ENG: http://hugin.info/137314/R/1657741/536263.pdf

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

@ThingsExpo Stories
IoT is at the core or many Digital Transformation initiatives with the goal of re-inventing a company's business model. We all agree that collecting relevant IoT data will result in massive amounts of data needing to be stored. However, with the rapid development of IoT devices and ongoing business model transformation, we are not able to predict the volume and growth of IoT data. And with the lack of IoT history, traditional methods of IT and infrastructure planning based on the past do not app...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, will examine the regulations and provide insight on how it affects technology, challenges the established rules and will usher in new levels of diligence...
DX World EXPO, LLC., a Lighthouse Point, Florida-based startup trade show producer and the creator of "DXWorldEXPO® - Digital Transformation Conference & Expo" has announced its executive management team. The team is headed by Levent Selamoglu, who has been named CEO. "Now is the time for a truly global DX event, to bring together the leading minds from the technology world in a conversation about Digital Transformation," he said in making the announcement.
In the enterprise today, connected IoT devices are everywhere – both inside and outside corporate environments. The need to identify, manage, control and secure a quickly growing web of connections and outside devices is making the already challenging task of security even more important, and onerous. In his session at @ThingsExpo, Rich Boyer, CISO and Chief Architect for Security at NTT i3, discussed new ways of thinking and the approaches needed to address the emerging challenges of security i...
Internet of @ThingsExpo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devic...
What sort of WebRTC based applications can we expect to see over the next year and beyond? One way to predict development trends is to see what sorts of applications startups are building. In his session at @ThingsExpo, Arin Sime, founder of WebRTC.ventures, discussed the current and likely future trends in WebRTC application development based on real requests for custom applications from real customers, as well as other public sources of information.
"The Striim platform is a full end-to-end streaming integration and analytics platform that is middleware that covers a lot of different use cases," explained Steve Wilkes, Founder and CTO at Striim, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
SYS-CON Events announced today that Calligo, an innovative cloud service provider offering mid-sized companies the highest levels of data privacy and security, has been named "Bronze Sponsor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Calligo offers unparalleled application performance guarantees, commercial flexibility and a personalised support service from its globally located cloud plat...
SYS-CON Events announced today that Massive Networks will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Massive Networks mission is simple. To help your business operate seamlessly with fast, reliable, and secure internet and network solutions. Improve your customer's experience with outstanding connections to your cloud.
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.
SYS-CON Events announced today that Datera, that offers a radically new data management architecture, has been named "Exhibitor" of SYS-CON's 21st International Cloud Expo ®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Datera is transforming the traditional datacenter model through modern cloud simplicity. The technology industry is at another major inflection point. The rise of mobile, the Internet of Things, data storage and Big...
While the focus and objectives of IoT initiatives are many and diverse, they all share a few common attributes, and one of those is the network. Commonly, that network includes the Internet, over which there isn't any real control for performance and availability. Or is there? The current state of the art for Big Data analytics, as applied to network telemetry, offers new opportunities for improving and assuring operational integrity. In his session at @ThingsExpo, Jim Frey, Vice President of S...
"DX encompasses the continuing technology revolution, and is addressing society's most important issues throughout the entire $78 trillion 21st-century global economy," said Roger Strukhoff, Conference Chair. "DX World Expo has organized these issues along 10 tracks with more than 150 of the world's top speakers coming to Istanbul to help change the world."
"We provide IoT solutions. We provide the most compatible solutions for many applications. Our solutions are industry agnostic and also protocol agnostic," explained Richard Han, Head of Sales and Marketing and Engineering at Systena America, in this SYS-CON.tv interview at @ThingsExpo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We are focused on SAP running in the clouds, to make this super easy because we believe in the tremendous value of those powerful worlds - SAP and the cloud," explained Frank Stienhans, CTO of Ocean9, Inc., in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
"We've been engaging with a lot of customers including Panasonic, we've been involved with Cisco and now we're working with the U.S. government - the Department of Homeland Security," explained Peter Jung, Chief Product Officer at Pulzze Systems, in this SYS-CON.tv interview at @ThingsExpo, held June 6-8, 2017, at the Javits Center in New York City, NY.
The financial services market is one of the most data-driven industries in the world, yet it’s bogged down by legacy CPU technologies that simply can’t keep up with the task of querying and visualizing billions of records. In his session at 20th Cloud Expo, Karthik Lalithraj, a Principal Solutions Architect at Kinetica, discussed how the advent of advanced in-database analytics on the GPU makes it possible to run sophisticated data science workloads on the same database that is housing the rich...
Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution and join Akvelon expert and IoT industry leader, Sergey Grebnov, in his session at @ThingsExpo, for an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience.
"MobiDev is a Ukraine-based software development company. We do mobile development, and we're specialists in that. But we do full stack software development for entrepreneurs, for emerging companies, and for enterprise ventures," explained Alan Winters, U.S. Head of Business Development at MobiDev, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
SYS-CON Events announced today that DXWorldExpo has been named “Global Sponsor” of SYS-CON's 21st International Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Digital Transformation is the key issue driving the global enterprise IT business. Digital Transformation is most prominent among Global 2000 enterprises and government institutions.